Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Phenacetin and analgesic nephropathy

A Burry, J Hopkins

    The Medical Journal of Australia
    |June 11, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Removing phenacetin from popular analgesics significantly reduced analgesic nephropathy incidence. However, nephropathy persisted with other compound analgesics, indicating ongoing risks from different formulations.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Challenges of determining the relative contribution of determinants of health on population health: a Canadian perspective.

    Perspectives in public health·2024
    Same author

    Real-world prevalence across 159 872 patients with cancer supports the clinical utility of TMB-H to define metastatic solid tumors for treatment with pembrolizumab.

    Annals of oncology : official journal of the European Society for Medical Oncology·2021
    Same author

    Scrapie infection and endogenous retroviral expression in sheep lymphoid tissues.

    Veterinary immunology and immunopathology·2021
    Same author

    Variation in zoobenthic blue carbon in the Arctic's Barents Sea shelf sediments.

    Philosophical transactions. Series A, Mathematical, physical, and engineering sciences·2020
    Same author

    Burkholderia pseudomallei multi-centre study to establish EUCAST MIC and zone diameter distributions and epidemiological cut-off values.

    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2020
    Same author

    An open and closed case: timing of closure following laparostomy.

    Annals of the Royal College of Surgeons of England·2020
    Same journal

    Responding to the Revised First Nations Health and Cultural Safety Accreditation Standards in Australian Primary Medical Education: Institutional Principles and Qualities for Meaningful Progress.

    The Medical journal of Australia·2026
    Same journal

    Multimorbidity Clusters Among People Aged 65 Years and Over in Australia: A Nationwide Cross-Sectional Data Linkage Study.

    The Medical journal of Australia·2026
    Same journal

    Reducing Nitrous Oxide Emissions Across the Melbourne Biomedical Precinct.

    The Medical journal of Australia·2026
    Same journal

    Still Treating Yesterday's Risk? Reconsidering Antiviral Use for Mild-to-Moderate COVID-19 Cases in a Broadly Immune Population.

    The Medical journal of Australia·2026
    Same journal

    Striving for Racial Equity in Oral Cancer Research: A Case Study.

    The Medical journal of Australia·2026
    Same journal

    Progressing Cross-Sector Collaboration for People With Eating Disorders and Higher Weight: Priority Actions From an Expert Roundtable Using a Modified Nominal Group Technique.

    The Medical journal of Australia·2026
    See all related articles

    Area of Science:

    • Nephrology
    • Pharmacology
    • Toxicology

    Background:

    • Analgesic nephropathy is a serious kidney disease linked to long-term use of certain pain relievers.
    • Phenacetin, a component in some compound analgesics, was previously associated with a high incidence of this condition.
    • Concerns over analgesic nephropathy led to regulatory actions and reformulation of popular pain medications.

    Purpose of the Study:

    • To evaluate the impact of phenacetin withdrawal on the prevalence of analgesic nephropathy.
    • To identify potential nephropathy risks associated with phenacetin-free compound analgesics.
    • To investigate the diagnostic significance of crystal formation in analgesic nephropathy.

    Main Methods:

    • A prospective autopsy survey of 322 adults was conducted after phenacetin removal from a common analgesic.

    Related Experiment Videos

  • Comparison of findings with data from an earlier survey conducted when phenacetin was still in use.
  • Histopathological examination of kidney tissues to identify signs of analgesic nephropathy and crystal presence.

    • Main Results:

    • A notable reduction in the incidence of advanced and early-stage analgesic nephropathy was observed post-phenacetin withdrawal.
    • Active nephropathy was still detected in individuals using compound analgesics that did not contain phenacetin.
    • Crystals found in nephropathy tissues were identified as non-specific breakdown products, lacking diagnostic value.

    Conclusions:

    • The removal of phenacetin from compound analgesics demonstrably decreased the occurrence of analgesic nephropathy.
    • Alternative formulations of compound analgesics may still pose a risk for developing nephropathy.
    • Crystal identification in kidney tissue is not a reliable diagnostic marker for analgesic nephropathy.